K142505 is an FDA 510(k) clearance for the ClearPoint System. This device is classified as a Neurological Stereotaxic Instrument (Class II - Special Controls, product code HAW).
Submitted by Mri Interventions, Inc. (Irvine, US). The FDA issued a Cleared decision on October 21, 2015, 411 days after receiving the submission on September 5, 2014.
This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.4560.
| 510(k) Number | K142505 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | September 05, 2014 |
| Decision Date | October 21, 2015 |
| Days to Decision | 411 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | HAW - Neurological Stereotaxic Instrument |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 882.4560 |